Cytek BioSciences Inc
Cytek BioSciences Inc (CTKB) Implied Volatility Current
CTKB implied volatility is 325%. IV Rank is 75%, placing current premiums in the top of their 52-week range.
Read more
Tracking CTKB implied volatility helps you identify when options premiums on Cytek BioSciences Inc are historically cheap or expensive, and where the best trades are hiding. Cytek BioSciences Inc implied volatility reflects the market's expectation of future price movement: when CTKB IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Cytek BioSciences Inc's implied volatility current levels in real time and filter for high-probability trades.
Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For CTKB, tracking metrics like CTKB IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on CTKB signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system, which leverages full spectrum profiling technology to further broaden potential applications across cell analysis. The company also provides reagents and kits, including cFluor reagents, which are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils.
In addition, it offers automated micro-sampling system and automated sample loader system, which are automated plate loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific region; and through distributors or sales agents in European, Latin American, the Middle Eastern, and the Asia-Pacific countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.
Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where CTKB implied volatility sits today versus where it has been. Our scanner ranks Cytek BioSciences Inc implied volatility against its historical range, surfaces extremes in CTKB IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Cytek BioSciences Inc IV is rich or cheap — measure it, then act on it.
Implied Volatility
IV is near its yearly peak - premiums are expensive, favoring sellers.
As of September 18, 2026
Trade options with IV on your side
Track CTKB IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.
Start your 14-day free trial→